Insurer Zurich has enhanced its critical illness offering for new customers, with expanded coverage of a variety of heart diseases and other recognisable conditions.
The group focused its overhaul on its three main claims areas - cancer, heart and neurological disorders - updating 50 definitions and increasing its total coverage to 85 conditions. Zurich said it paid out £65.4m in the last year, with 59% of its total 788 critical illness claims, worth £48.3m, being in relation to cancer. Data from Equifax Touchstone published in March showed critical illness sales for 2015 were up 33% across the industry, compared with 2014, while sales of term assurance (including term policies with critical illness incorporated) were up 11%. In its new offering t...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes